Goodrays Secures Major Funding, Appoints Former Liquid Death Executive
July 14, 2025, 3:46 pm
Location: United States, California, Santa Monica
Employees: 51-200
Founded date: 2017
Total raised: $244M
Goodrays, a rapidly expanding UK CBD brand, recently closed a significant €5.7 million Series A funding round. This investment drew support from Guinness Ventures and a notable list of celebrity investors. The company simultaneously announced the appointment of Ben Dando, formerly of Liquid Death, as its new Managing Director. This strategic capital infusion targets aggressive growth. It coincides with surging demand for functional beverages. Goodrays boasts three consecutive years of doubled revenue and profitability. The funding positions Goodrays to capitalize on the booming UK CBD market. Full market authorization for CBD products is anticipated soon. The brand focuses on mental well-being solutions. It aims to disrupt the traditional drinks industry. Goodrays cements its status as a market innovator.
Goodrays, a UK-based CBD beverage innovator, just announced a significant financial boost. The company closed a €5.7 million Series A funding round. This major investment comes from various sources. Guinness Ventures led the institutional participation. Existing and new institutional investors also contributed. Several celebrity figures provided backing. Vernon Kay and Tess Daly are prominent among them. Sporting stars Ed Leigh and Ben Skinner also invested. This capital infusion signals strong market confidence in Goodrays.
The funding coincides with a key executive appointment. Ben Dando joins Goodrays as its new Managing Director. Dando brings substantial industry experience. He previously served as International Managing Director for Liquid Death. His leadership is expected to drive further expansion. Liquid Death recently exited the UK market. This fact highlights Goodrays' contrasting trajectory. Goodrays thrives where others faltered. Dando's expertise in scaling beverage brands is critical. His appointment underscores Goodrays' ambitious growth plans.
Goodrays boasts an impressive financial track record. The company has doubled its revenue. This achievement spans three consecutive years. Profitability also doubled during this period. Such consistent growth is rare. It reflects strong product acceptance. It shows effective market penetration. The brand secured listings with four of the UK's largest retailers in 2024. This expanded retail footprint is a major milestone. It broadens consumer access to Goodrays products.
The timing of this investment is crucial. The UK CBD market is experiencing rapid expansion. It reached €799 million in 2021. Projections indicate it will hit €1.1 billion by year-end. This growth signals a burgeoning consumer interest. Regulatory clarity is also on the horizon. Full market authorization for CBD products in the UK is expected. This landmark event should occur early next year. It will reshape the industry landscape. Goodrays is poised to leverage these market shifts.
Goodrays positions itself as a leader in functional beverages. The brand focuses on mental well-being. It offers CBD-infused drinks. These products provide an alternative to traditional options. Many existing drinks are high in sugar. Others contain hard alcohol. Ultra-processed foods dominate shelves. Goodrays offers a different path. It aims to help busy minds find calm. It provides clarity through its premium products. This vision resonates with modern consumers. People increasingly prioritize their mental health.
The company's mission is clear. It seeks to build the UK's leading premium functional drinks brand. Goodrays believes the food and drink industry long ignored mental well-being. Its products directly address this oversight. They offer a healthier choice. This approach disrupts established categories. It challenges the status quo. The brand emphasizes adding benefits. It focuses on what can improve consumers' lives. This contrasts with brands focused on 'cutting out' ingredients.
The capital secured will fuel strategic initiatives. Goodrays plans to accelerate its market presence. It will likely invest in marketing and distribution. Product innovation will also receive attention. Expanding research and development is probable. The goal is to solidify its market-leading position. Goodrays aims to become a legacy brand. It is not merely another functional drink company. It strives to create a lasting impact.
The functional drinks category is dynamic. It is fast-moving. Consumer engagement with the drinks industry is at a tipping point. More consumers seek health-conscious options. They demand beverages that offer tangible benefits. CBD-infused drinks fit this emerging trend perfectly. They offer perceived relaxation and clarity. Goodrays capitalizes on this evolving consumer demand. It offers a solution for modern stressors.
Goodrays' success demonstrates a broader trend. The wellness industry continues to boom. Consumers are more educated about their choices. They seek natural ingredients. They prioritize mental and physical health. CBD products, when properly regulated, offer significant potential. Goodrays is at the forefront of this movement. Its strategic investment and leadership changes mark a pivotal moment. The company is set for its next phase of significant growth. It stands ready to further disrupt the industry.
Goodrays, a UK-based CBD beverage innovator, just announced a significant financial boost. The company closed a €5.7 million Series A funding round. This major investment comes from various sources. Guinness Ventures led the institutional participation. Existing and new institutional investors also contributed. Several celebrity figures provided backing. Vernon Kay and Tess Daly are prominent among them. Sporting stars Ed Leigh and Ben Skinner also invested. This capital infusion signals strong market confidence in Goodrays.
The funding coincides with a key executive appointment. Ben Dando joins Goodrays as its new Managing Director. Dando brings substantial industry experience. He previously served as International Managing Director for Liquid Death. His leadership is expected to drive further expansion. Liquid Death recently exited the UK market. This fact highlights Goodrays' contrasting trajectory. Goodrays thrives where others faltered. Dando's expertise in scaling beverage brands is critical. His appointment underscores Goodrays' ambitious growth plans.
Goodrays boasts an impressive financial track record. The company has doubled its revenue. This achievement spans three consecutive years. Profitability also doubled during this period. Such consistent growth is rare. It reflects strong product acceptance. It shows effective market penetration. The brand secured listings with four of the UK's largest retailers in 2024. This expanded retail footprint is a major milestone. It broadens consumer access to Goodrays products.
The timing of this investment is crucial. The UK CBD market is experiencing rapid expansion. It reached €799 million in 2021. Projections indicate it will hit €1.1 billion by year-end. This growth signals a burgeoning consumer interest. Regulatory clarity is also on the horizon. Full market authorization for CBD products in the UK is expected. This landmark event should occur early next year. It will reshape the industry landscape. Goodrays is poised to leverage these market shifts.
Goodrays positions itself as a leader in functional beverages. The brand focuses on mental well-being. It offers CBD-infused drinks. These products provide an alternative to traditional options. Many existing drinks are high in sugar. Others contain hard alcohol. Ultra-processed foods dominate shelves. Goodrays offers a different path. It aims to help busy minds find calm. It provides clarity through its premium products. This vision resonates with modern consumers. People increasingly prioritize their mental health.
The company's mission is clear. It seeks to build the UK's leading premium functional drinks brand. Goodrays believes the food and drink industry long ignored mental well-being. Its products directly address this oversight. They offer a healthier choice. This approach disrupts established categories. It challenges the status quo. The brand emphasizes adding benefits. It focuses on what can improve consumers' lives. This contrasts with brands focused on 'cutting out' ingredients.
The capital secured will fuel strategic initiatives. Goodrays plans to accelerate its market presence. It will likely invest in marketing and distribution. Product innovation will also receive attention. Expanding research and development is probable. The goal is to solidify its market-leading position. Goodrays aims to become a legacy brand. It is not merely another functional drink company. It strives to create a lasting impact.
The functional drinks category is dynamic. It is fast-moving. Consumer engagement with the drinks industry is at a tipping point. More consumers seek health-conscious options. They demand beverages that offer tangible benefits. CBD-infused drinks fit this emerging trend perfectly. They offer perceived relaxation and clarity. Goodrays capitalizes on this evolving consumer demand. It offers a solution for modern stressors.
Goodrays' success demonstrates a broader trend. The wellness industry continues to boom. Consumers are more educated about their choices. They seek natural ingredients. They prioritize mental and physical health. CBD products, when properly regulated, offer significant potential. Goodrays is at the forefront of this movement. Its strategic investment and leadership changes mark a pivotal moment. The company is set for its next phase of significant growth. It stands ready to further disrupt the industry.